Compounds > organophosphonates
Page last updated: 2024-09-05

organophosphonates and caffeine

organophosphonates has been researched along with caffeine in 4 studies

Compound Research Comparison

Studies
(organophosphonates)		Trials
(organophosphonates)		Recent Studies (post-2010)
(organophosphonates)		Studies
(caffeine)		Trials
(caffeine)		Recent Studies (post-2010) (caffeine)
9,9688803,59625,5012,3936,825

Protein Interaction Comparison

ProteinTaxonomyorganophosphonates (IC50)caffeine (IC50)
AcetylcholinesteraseHomo sapiens (human)7.25

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vernikova, LM; Zhukovskaia, SA1
Holý, A; Kmonícková, E; Potmesil, P; Zídek, Z1
Holý, A; Kmonícková, E; Krecmerová, M; Potmesil, P; Zídek, Z1
Li, Y; Liu, J; Qian, X; Shao, J; Shen, K; Xu, Y1

Reviews

1 review(s) available for organophosphonates and caffeine

ArticleYear
[Treatment with flocculants: a new effective method of purification of solutions].
    Antibiotiki, 1969, Volume: 14, Issue:7

    Topics: Acrylates; Aluminum Silicates; Amides; Anti-Bacterial Agents; Caffeine; Electrolytes; Fats; Formaldehyde; Maleates; Organophosphonates; Pharmaceutic Aids; Polyethylenes; Polymers; Polysaccharides; Proteins; Solutions; Styrenes; Technology, Pharmaceutical

1969

Other Studies

3 other study(ies) available for organophosphonates and caffeine

ArticleYear
Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine.
    European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2

    Topics: 2-Aminopurine; Adenine; Adjuvants, Immunologic; Animals; Anti-HIV Agents; Caffeine; Cell Survival; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Dihydropyridines; Dose-Response Relationship, Drug; Female; Flavins; Humans; Interleukin-10; Lipopolysaccharides; Macrophage Inflammatory Proteins; Macrophages; Mice; Mice, Inbred C57BL; Molecular Structure; Organophosphonates; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Theophylline; Triazoles; Tumor Necrosis Factor-alpha

2006
Nucleotide analogues with immunobiological properties: 9-[2-Hydroxy-3-(phosphonomethoxy)propyl]-adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives.
    European journal of pharmacology, 2006, Jul-01, Volume: 540, Issue:1-3

    Topics: Adenine; Animals; Caffeine; Cell Survival; Cytokines; Dihydropyridines; Dose-Response Relationship, Drug; Female; Gene Expression; Interferon-gamma; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Nucleotides; Organophosphonates; Organophosphorus Compounds; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles

2006
E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Journal of cellular biochemistry, 2012, Volume: 113, Issue:10

    Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Apoptotic Protease-Activating Factor 1; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Caffeine; Cell Cycle Proteins; Comet Assay; Cyclin-Dependent Kinase Inhibitor p21; DNA Breaks, Double-Stranded; Dose-Response Relationship, Drug; E2F1 Transcription Factor; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Gene Knockout Techniques; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; K562 Cells; M Phase Cell Cycle Checkpoints; MCF-7 Cells; Naphthalimides; Organophosphonates; Protein Serine-Threonine Kinases; Rats; Signal Transduction; Time Factors; Tumor Suppressor Protein p53

2012